Special Issue "Secondary Osteoporosis in Adults 2.0"
Deadline for manuscript submissions: 30 April 2022.
Unit for Bone Metabolism Diseases and Diabetes, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Interests: adrenal diseases; parathyroid diseases; osteoporosis; metabolic bone diseases; endocrine hypertension
Special Issues and Collections in MDPI journals
This Special Issue is the continuation of our previous Special Issue "Secondary Osteoporosis in Adults".
It is known that skeletal fragility may represent the effect of several systemic diseases and drugs, leading to “secondary osteoporosis”. The typical characteristic of secondary osteoporosis is an alteration of bone quality that, in turn, increases the risk of fractures even in the presence of normal or slightly reduced bone mineral density.
Very often, fragility fractures are the manifest symptoms of these underlying diseases that otherwise could be completely asymptomatic for many years. The diagnosis of a systemic disease in a patient with an inexplicable form of osteoporosis or fragility fracture may often help to prevent the extra-skeletal consequences of the underlying disease. Moreover, a correct diagnosis reduces the risk of inadequate treatments, and this is particularly important in secondary osteoporosis as far as, by curing the underlying disease, we have a good opportunity for reducing the fracture risk.
In this Special Issue, we will include several reviews covering the most frequent and important forms of secondary osteoporosis due to obesity and diabetes, or to endocrine, gastrointestinal, hematologic, rheumatological, neuro-psychiatric and kidney diseases, and, finally, genetic disorders and drugs. Moreover, we welcome your contributions in the form of original research on all the aspects of secondary osteoporosis.
Dr. Iacopo Chiodini
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Endocrine diseases
- Gastrointestinal diseases
- Hematologic diseases
- Genetic diseases
- Neuro-psychiatric diseases
- Kidney diseases
- Bone-impacting drugs